Divi's Laboratories Ltd.

NSE: DIVISLAB | BSE: 532488 | ISIN: INE361B01024 | Industry: Pharmaceuticals
| Expensive Performer
6857.5000 100.50 (1.49%)
NSE Jul 06, 2026 15:42 PM
Volume: 402.1K
 

6857.50
1.49%
Deven Choksey
We expect the company to grow its Revenue/EBITDA/PAT at a CAGR of 15.3% / 20% / 18.2% for the period of FY26-FY28.
Divi's Laboratories .. has an average target of 6702.67 from 6 brokers.
More from Divi's Laboratories Ltd.
Recommended